Peter Sands, executive director of The Global Fund to Fight AIDS, Tuberculosis and Malaria, joins Steve and Andrew in exploring the chasm separating the world of finance and economists from that of public health, the extraordinary threats the pandemic poses to historical gains in development and global health, and the rapidly evolving role of the Global Fund in racing to support partner countries in their response to the coronavirus.

In this episode, Andrew asks Steve to interpret the guidelines issued by President Trump yesterday in a three-phase process of reopening.

Dr. Christopher Murray joins Steve Morrison and Andrew Schwartz to discuss the “Murray Model,” what a rolling reopening of the economy would look like and what that would do to the Murray Model projections, which states may be ready to reopen, and what hotspots he’s worried about most.

In this episode, Susan Glasser, staff writer at The New Yorker, joins Steve and Andrew to discuss the full range of rapidly evolving issues surrounding President Trump and the White House’s engagement with the coronavirus pandemic and the companion economic crisis.

Steve and Andrew are joined by Congresswoman Susan Brooks (R-IN05) to talk about her work on the CSIS Commission on Strengthening America’s Health Security and her experience working through Covid-19.

Ron Klain, former Ebola response coordinator in the Obama Administration, discusses the deep structural changes that are required post-pandemic for America to resume as a global leader, what future observers might conclude on how we reached this treacherous moment, and what gives Ron confidence and hope.

Steve and Andrew speak with Helen Branswell, a premiere journalist and one of the world’s leading experts on dangerous infectious disease outbreaks, based for the past five years at STAT.

Andrew and Steve talk to Dr. Tom Frieden, President and CEO of Resolve to Save Lives and former CDC Director, about the infections and deaths in New York and the risk to healthcare workers, the need for clear federal guidance, and how we can organize to minimize the harm from this pandemic.

Andrew and Steve talk to Secretary John Wiesman on the testing and hospital capacity in Washington state, the scramble for resources that states are finding themselves in and how Washington is working with the private sector to develop these products, and when social distancing might end.

Steve speaks with Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson, about the unknowns surrounding the COVID-19 virus, the Chinese response, and the role J&J is playing in developing a vaccine.

Steve speaks with Jeremy Farrar, Director of the Wellcome Trust, about his experience with SARS in Vietnam, the number of unknowns surrounding the coronavirus, China's unprecedented response and its impacts, and the role Wellcome is playing.

Andrew and Steve are joined by Jude Blanchette to discuss how the U.S. and China are dealing with the pandemic in their own countries.

Andrew and Steve talk to Fmr. FDA Commissioner Dr. Margaret "Peggy" Hamburg about what’s happened with testing in the U.S., the ‘global arms race’ to develop a vaccine, and how the U.S. and the world can develop, produce, and distribute any potential vaccine in an equitable way.

Steve and Andrew invite CSIS's Kathleen Hicks to discuss how the military can respond to COVID-19, and to what extent that can be done.

Steve and Andrew discuss what’s happening with the U.S. response: the wholesale suspension of work and cultural events, the mixed messages coming from the Administration, and the unknown period we’re currently in as we wait for the worst part of the pandemic.

Steve and Andrew invite Stephanie Segal to discuss the economic shocks COVID-19 is causing, the so-far inadequate policy response, and the possible prolonged economic crisis to come.

Steve and Andrew speak with Heather Conley on the quarantine of 16 million people in northern Italy; how it came about, what it will mean for Italy’s economy and politics, and how Italy’s neighbors are responding.

Steve Morrison speaks with Dr. Julie Gerberding on the current mood in Congress, the transition in the United States from a phase of containment to one of managing the spread COVID-19, and her outstanding concerns and reasons for hope.

CSIS’s Steve Morrison and Andrew Schwartz discuss newly concentrated hotspots and the politicization of COVID-19, and how an adequate response to the outbreak requires more leadership, clarity and trust.

Steve speaks with Dr. Mike Ryan, executive director of the WHO's Health Emergencies Programme about what dynamics are driving this outbreak, why it should be seen as a security risk as well as a health risk, and what the WHO is doing.

Steve speaks with Orin Levine, director of Vaccine Delivery at the Bill & Melinda Gates Foundation about the investments the Foundation is making into the epidemic response, the urgent need for diagnostics and treatments, and how this infection might play out over the next year.

As knowledge on COVID-19 evolves, Take as Directed will bring you the latest updates in this miniseries Coronavirus Crisis Update.

Rebecca Martin discusses the CDC’s work on training field disease detectives and laboratory workers worldwide, how the CDC works across the world to respond to outbreaks, and the Commission’s recommendation that the US re-invest in Global Health Security Agenda (GHSA).

Ambassador Jimmy Kolker and Carolyn Reynolds discuss trends in global investment in health security, and the Commission's recommendations to invest in pandemic preparedness measures.

Dr. Richard Hatchett discusses CEPI's role in developing technologies to fight against high priority public health threats and emerging infectious diseases.